Thousands of Pradaxa lawsuits have been filed on behalf of patients who allegedly suffered dangerous episodes of uncontrollable internal bleeding while using this medication. In May 2014, Boehringer Ingelheim agreed to fund a $650 million Pradaxa settlement to resolve many of those claims.
Are You Eligible to File a Pradaxa Lawsuit?
You may be eligible to file a Pradaxa lawsuit if you or a loved one experienced uncontrollable, internal bleeding while using this blood thinning medication. The nationwide law firm of Bernstein Liebhard LLP is now investigating claims on behalf of Pradaxa patients who suffered these serious complications, including:
- Cerebral Hemorrhage, or Brain Bleeds
- Gastrointestinal Bleeding, or Stomach Bleeds
- Rectal Bleeding
- Kidney Bleeding
- Heart Attack
To learn whether or not you might be eligible for compensation, please contact our legal staff today by calling (888) 994-5118.
Pradaxa: What’s the Problem?
When Pradaxa was approved in October 2010, it was intended as a major improvement over warfarin, a blood thinner that has been on the market for decades. Marketing materials for the medication promised that Pradaxa patients would not have to follow dietary restrictions or undergo regular blood monitoring, both of which are required with the use of warfarin. However, until October 2015, there was no approved antidote to reverse internal bleeding that sometimes occurs with Pradaxa use. As such, even a minor trauma – such as a bump on the head – could become a serious or fatal event for a Pradaxa patient. By contrast, internal bleeding associated with warfarin can be stopped via the administration of vitamin K.
In recent years, a number of reports and studies have raised questions about Pradaxa’s association with internal bleeding:
- May 2012: The Institute of Safe Medication Practices (ISMP) reported that Pradaxa was linked to more deaths and injuries in 2011 than any of the 800 other drugs it reviewed.
- May 2013: Research published online in the Journal of Neurosurgery found that head trauma victims were more likely to die from brain bleeding if they had been using Pradaxa in comparison to patients taking warfarin. Read More
- October 2013: An ISMP analysis of the FDA adverse event database found that Pradaxa was associated with more incidents in 2012 than any other medication. The group noted that the blood thinner had been implicated in 3,292 adverse events and 582 deaths, most of which involved instances of serious internal bleeding. Read More
- February 2014: Emails, memos and internal presentations unsealed in the course of Pradaxa lawsuits suggested that some at Boehringer Ingelheim feared that release of a certain study would raise questions about claims that Pradaxa did not require patients to undergo frequent blood testing. According to The New York Times, the study suggested that some Pradaxa patients absorbed too little of the drug for it to be effective. Other patients were found to absorb too much, putting them at risk for life-threatening episodes of internal bleeding. Read More
- May 2014: An FDA review finds a higher risk of major gastrointestinal bleeding with use of Pradaxa as compared to warfarin. The agency’s study was based on data from more than 134,000 Medicare patients, 65 years or older. Read More
Pradaxa Litigation Updates
- May 2014: Boehringer Ingelheim agrees to pay $650 million to settle Pradaxa lawsuits. The proposed Pradaxa settlement could resolve more than 2,500 cases pending in a federal litigation underway in Illinois, as well as an additional 1,500 cases filed in state courts in Illinois, Connecticut, California and Delaware.
- August 2012: A multidistrict litigation is established for all federally-filed Pradaxa bleeding cases. Per an Initial Transfer Order dated August 8, 2012, the new litigation will be located in the U.S. District Court, Southern District of Illinois. All of the Pradaxa lawsuits included in the centralized proceeding were filed on behalf of patients who allegedly experienced dangerous episodes of internal bleeding while using the medication. They further allege that the drug’s manufacturer failed to provide patients with proper warnings regarding these risks, including the lack an antidote to reverse Pradaxa’s anticoagulant effects.
Pradaxa Lawsuit Reviews
Bernstein Liebhard LLP continues to offer free legal consults to individuals who may have been harmed due to Pradaxa bleeding. To learn more about your legal rights, please call (888) 994-5118.
Last Modified: February 24, 2016